Editing domains of aminoacyl tRNA synthetases correct tRNA charging errors to maintain translational fidelity. A mutation in the editing domain of alanyl tRNA synthetase (AlaRS) in Aars sti mutant mice results in an increase in the production of serine-mischarged tRNA Ala and the degeneration of cerebellar Purkinje cells. Here, using positional cloning, we identified Ankrd16, a gene that acts epistatically with the Aars sti mutation to attenuate neurodegeneration. ANKRD16, a vertebrate-specific protein that contains ankyrin repeats, binds directly to the catalytic domain of AlaRS. Serine that is misactivated by AlaRS is captured by the lysine side chains of ANKRD16, which prevents the charging of serine adenylates to tRNA Ala and precludes serine misincorporation in nascent peptides. The deletion of Ankrd16 in the brains of Aars sti/sti mice causes widespread protein aggregation and neuron loss. These results identify an aminoacid-accepting co-regulator of tRNA synthetase editing as a new layer of the machinery that is essential to the prevention of severe pathologies that arise from defects in editing. 5 1 0 | N A t U r e | V O l 5 5 7 | 2 4 M A Y 2 0 1 8
Accurate aminoacylation of tRNAs by tRNA synthetases establishes the universal genetic code and occurs in two steps: the activation of the selected amino acid with ATP to form an aminoacyl adenylate, and the transfer of the aminoacyl group of the adenylate to the 2′-or 3′-OH of the cognate tRNA. However, structural similarities between some amino acids allow for misactivation of non-cognate amino acids and subsequent misacylation of tRNA. These errors can be corrected by the hydrolytic editing functions found in many tRNA synthetases 1, 2 . Editing can occur after amino acid misactivation but before aminoacyl transfer, or after the aminoacylation of tRNA, known as pre-transfer and post-transfer editing, respectively. Pre-transfer editing occurs at either the active site of aminoacylation or at a distinct editing site, whereas post-transfer editing occurs only at the editing site of these enzymes [3] [4] [5] .
The importance of tRNA synthetase editing, including editing by the alanyl tRNA synthetase (AlaRS, which is encoded by Aars in mice), has been shown in several organisms [6] [7] [8] [9] [10] [11] . Although AlaRS misactivates both glycine and serine, the misactivation of serine seems to have more serious consequences, perhaps due to the presence of d-aminoacyl-tRNA deacylases [12] [13] [14] that act on Gly-tRNA Ala . Previously we showed that sticky (sti) mutant mice that have a point mutation (A734E) in the editing domain of AlaRS have ubiquitinated protein aggregates in cerebellar Purkinje cells, resulting in the degeneration of these neurons 9 . The sti mutation results in only a twofold increase in the generation of Ser-tRNA Ala , demonstrating that Purkinje cells are particularly sensitive to the loss of AlaRS editing 9 .
Here we identified a new vertebrate-specific gene, Ankrd16, which greatly attenuates misfolded aggregate formation and Purkinje cell degeneration in Aars sti/sti mice. The deletion of Ankrd16 in other Aars sti/sti neurons also caused the formation of ubiquitinated protein aggregates and neuron death. ANKRD16 binds to AlaRS and prevents the misincorporation of serine at alanine codons in nascent peptides by stimulating serine-dependent ATP hydrolysis before tRNA aminoacylation via the acceptance of misactivated serines. Our data collectively reveal ANKRD16 as a co-regulator of AlaRS that protects against assaults on translation fidelity and proteostasis in mammalian neurons.
Ankrd16 suppresses Purkinje cell loss in sticky mice
Aars sti/sti mice on the inbred C57BL/6J (B6) genetic background are ataxic, with cerebellar Purkinje cell degeneration beginning at three weeks of age 9 . However, neither ataxia nor Purkinje cell degeneration was apparent in nine out of ten 12-16-month-old F 2 Aars sti/sti mice from a B6.Aars sti/+ and CAST/Ei (CAST) mating, suggesting that CAST-derived alleles could suppress neuron loss. In agreement, two phenotypically distinct classes of N 1 Aars sti/sti offspring (generated from a backcross of F 1 B6/CAST Aars sti/sti mice to B6.Aars sti/+ mice) were observed at equal frequencies: mice with ataxia and extensive Purkinje cell loss similar to that of B6.Aars sti/sti mice, and mice without ataxia and little Purkinje cell loss (Extended Data Fig. 1a ). Suppression of the neurodegenerative phenotype was observed in 50% of backcross mice from crosses to CASA/RkJ (CASA, a strain closely related to CAST/Ei), but not in other crosses, which suggests that a single dominant allele from the CAST or CASA strains can suppress sti-mediated neurodegeneration (Extended Data Fig. 1a ).
Genome scans of affected and unaffected N 1 Aars sti/sti mice revealed that the Purkinje cell degeneration was suppressed in mice that were heterozygous for CAST alleles on proximal chromosome 2 (Extended Data Fig. 1b ). This locus (around 3.3 Mb) also segregated with the Aars sti/sti modifier gene from CASA, which suggests that these strains share the same suppressor gene. Transfer of the modifier of sticky Article reSeArcH (Msti) locus from the CAST genome onto the B6.Aars sti/sti genetic background rescued the decreased latency to fall in a rotarod test of three-month-old B6.Aars sti/sti mice and markedly reduced Purkinje cell death, although some neurons in the rostral cerebellum of these mice still degenerated (Fig. 1a, b ). Heterozygosity and homozygosity for CAST alleles in the Msti region similarly attenuated Purkinje cell loss, in agreement with the dominant nature of Msti (Fig. 1b ).
Ubiquitin punctae characteristic of protein inclusions were observed in many Purkinje cells in four-week-old B6.Aars sti/sti mice, but not in B6 or CAST mice (data not shown). As expected owing to the progressive Purkinje cell loss observed in sti mutant mice, the number of Purkinje cells that contained inclusions decreased by 6 and 12 weeks of age. However, very few Purkinje cells in B6.Msti CAST/B6 Aars sti/sti mice contained inclusions, even at later ages, which confirms the long-term protection of Purkinje cells (Fig. 1c) .
We further localized Msti to a 0.63-Mb region, and the coding regions of the protein-coding genes in this interval were amplified by PCR with reverse transcription (RT-PCR) from B6 and CAST cerebellar RNA and sequenced ( Fig. 2a ). Non-synonymous single nucleotide polymorphisms (SNPs) were observed in Il2ra, Fbxo18 and Ankrd16 (Fig. 2a ). However, with the exception of Il2ra, these SNPs were either not present in CASA (Fbxo18), which is an Aars sti/sti modifying strain, or were also present in MOLF (Ankrd16), a strain in which neurodegeneration is not rescued (Extended Data Fig. 1a, c) .
A strain-specific Ankrd16 transcript that contained a 138-bp cryptic exon (exon 5′) was also observed in B6 (with or without the Aars sti/sti mutation) and other non-rescuing strains, but was absent in CAST or CASA ( Fig. 2b , Extended Data Fig. 1d, e ). Sequence analysis of intron 5 suggested that the inclusion of this exon was due to an SNP that generated a novel alternative splice site ( Fig. 2c , Extended Data Fig. 1f ). Transcript levels of the correctly spliced Ankrd16 isoform (lacking exon 5′) were 3.3-fold and 5.3-fold higher in the congenic Msti CAST/B6 or CAST cerebellum relative to B6, respectively ( Fig. 2d ). Protein levels were 2.8 ± 0.2-fold and 3.9 ± 0.22-fold higher in the B6.Msti CAST/B6 and CAST cerebellum, respectively, and the Aars sti/sti mutation did not alter Ankrd16 splicing or protein levels ( Fig. 2e , Extended Data Fig. 1e , g). Increased ANKRD16 levels were also observed in other tissues from Msti CAST/B6 mice (Extended Data Fig. 1h ). The Ankrd16 transcript with exon 5′ contains a premature stop codon and is predicted to undergo nonsense-mediated decay; in agreement, truncated forms of ANKRD16 were not observed ( Fig. 2e , Extended Data Fig. 1g ). 
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Neurodegeneration in Aars sti/sti mice was modified neither by transgenic expression of the CAST Il2ra cDNA nor by deletion of Il2ra (data not shown). However, suppression of Aars sti/sti -mediated Purkinje cell loss was observed in mutant mice that carried a CAST BAC transgene containing the 3′-portion of the Il15ra gene, and the Fbxo18 and Ankrd16 genes ( Fig. 2f ). However, another transgenic line (Tg25L9-19) generated with this BAC in which Ankrd16 was deleted upon integration was not able to suppress Purkinje cell degeneration ( Fig. 2f , Extended Data Fig. 1i ). Indeed, transgenic expression of the Ankrd16 CAST coding sequence using the Purkinje cell-specific promoter Pcp2 in B6.Aars sti/sti mice suppressed the death of these neurons (Fig. 2g ).
ANKRD16 binds AlaRS to prevent mistranslation
Ankrd16 encodes a 39-kDa protein of unknown function that is composed of nine repeats of the ankyrin protein-protein interaction domain and is found only in vertebrates (Extended Data Fig. 2a , Extended Data Fig. 1j ). To identify proteins that interact with ANKRD16, we transgenically expressed Ankrd16-Myc under the control of the chicken beta-actin promoter and cytomegalovirus enhancer 15, 16 . Co-immunoprecipitation (co-IP) of ANKRD16 was performed using livers of transgenic and non-transgenic mice, and the immunoprecipitates were analysed by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Notably, AlaRS was the most abundant protein after the ANKRD16 bait protein (Extended Data Fig. 2a ). Interaction of ANKRD16 with wild-type or mutant AlaRS in both the liver and the brain was confirmed by co-IP and western blotting (data not shown and Fig. 3a ). Interactions between ANKRD16 and AlaRS were independent of both the epitope tag and the bait protein (Extended Data Fig. 2b, c) .
Co-IP experiments demonstrated that the AlaRS aminoacylation domain was efficiently co-immunoprecipitated by ANKRD16, and little interaction was observed in the absence of this domain (Fig. 3b , Extended Data Fig. 2b ). Affinity-capture experiments using purified AlaRS protein further demonstrated that the AlaRS catalytic domain was sufficient for interaction with ANKRD16 and that this interaction was direct (Extended Data Fig. 2e, Fig. 3c ). Furthermore, AlaRS did not co-immunoprecipitate ANKRD29-a protein that comprises eight ankyrin repeats (Extended Data Fig. 2d )-nor did ANKRD16 interact with tyrosyl-tRNA synthetase or tryptophanyl-tRNA synthetase ( Fig. 3c ). This suggests a specific ANKRD16-AlaRS interaction, with similar binding dynamics for both wild-type AlaRS and AlaRS(A734E) (Extended Data Fig. 2f ).
The AlaRS(A734E) mutation leads to increased death of Aars sti/sti embryonic fibroblasts when cultured with increasing concentrations of serine 9 . Msti CAST/B6 Aars sti/sti fibroblasts were more resistant to high serine concentrations than were B6.Aars sti/sti fibroblasts; at the highest concentrations (40 mM), less cell death was observed in Msti CAST/B6 Aars sti/sti than in B6 (Msti B6/B6 ) fibroblasts, which demonstrates that Ankrd16 suppresses serine-mediated cell death in Aars sti/sti cells ( Fig. 3d) .
Although ANKRD16 is a vertebrate-specific protein , mammalian and Escherichia coli AlaRS are highly conserved with around 67% similarity in the catalytic domain. Indeed, mouse ANKRD16 was able to bind E. coli AlaRS in affinity-capture experiments (Fig. 3c ), and reduced the death of E. coli with a severe editing-domain mutation (C666A/ Q584H) in AlaRS when grown on a serine gradient ( Fig. 3e ). Together, these results suggest that ANKRD16 influences the function of AlaRS.
Next, we used dipeptide formation on defined ribosome complexes as a read-out of charging and decoding fidelity. These experiments sufficiently detected serine mistranslation and AlaRS-mediated editing of Ser-tRNA Ala (Extended Data Fig. 3a, b ). When reactions using Ser-tRNA Ala and AlaRS were supplemented with alanine, a loss of fMet-Ser (fMet, N-formylmethionine) coincided with a gain of fMet-Ala ( Fig. 4a ), which is consistent with the reported post-transfer editing by AlaRS 7 . However, no obvious differences were observed between reactions using wild-type AlaRS or AlaRS(A734E), and ANKRD16 had no effect on either reaction in these experiments using mischarged tRNA.
By contrast, when deacyl tRNA Ala , serine and ATP were used, AlaRS(A734E) generated more fMet-Ser than did wild-type AlaRS, and ANKRD16 reduced the amount of this aberrant dipeptide in reactions with either AlaRS(A734E) or wild-type AlaRS (Extended Data Fig. 3c ). Although ANKRD16 interacts with a truncated AlaRS (AlaRS(1-455)) (Extended Data Fig. 2f ), no reduction in the amount of aberrant dipeptide was observed, which suggests that the editing and/or C-terminal domains of AlaRS may contribute to the function of ANKRD16. Furthermore, in the presence of ATP and a mixture of serine and alanine, ANKRD16 specifically decreased the formation of fMet-Ser, thereby increasing AlaRS(A734E) fidelity (that is, fMet-Ala/fMet-Ser) by a factor of around 20 (Fig. 4b ). Therefore, ANKRD16 acts before the formation of mischarged tRNA to enhance translational fidelity.
In agreement, ANKRD16 had no effect on subsequent steps of tRNA mischarging, including deacylation of mischarged Ser-tRNA Ala , transfer of the mischarged tRNA to EF-Tu, or amino acid activation or aminoacylation of the cognate amino acid alanine (Extended Data Fig. 3d-g ). In addition to post-transfer editing activity, pre-transfer editing has also been observed in AlaRS in E. coli 17 . Serine-dependent ATPase activity was also observed with mouse wild-type AlaRS in Article reSeArcH the absence of tRNA (Extended Data Fig. 4a ). However, this activity was decreased with both AlaRS(A734E) and AlaRS(1-455) ( Fig. 4c , Extended Data Fig. 4b ). ANKRD16 was able to restore that activity for AlaRS(A734E), but not for AlaRS , which further suggests that the editing domain contributes to the serine-dependent ATPase activity and/or the modulation of this activity by ANKRD16 ( Fig. 4c , Extended Data Fig. 4b, c ). Unexpectedly, ANKRD16 appeared to stimulate the tRNA-dependent precipitation of [ 3 H]serine but not of [ 3 H]alanine in reactions with AlaRS(A734E) (Extended Data Fig. 4d-f ). However, misactivated [ 3 H] serine was also precipitated in reactions without tRNA Ala , with approximately three linked-serine adducts per ANKRD16 (Extended Data Fig. 4g ). By contrast, [ 3 H]alanine-adduct formation per ANKRD16 with AlaRS(A734E), in the absence of tRNA Ala , was much lower (Extended Data Fig. 4h ). Furthermore, in the presence of tRNA Ala and AlaRS(A734E), alanine linked to ANKRD16 was negligible relative to that coupled to tRNA Ala (Fig. 4d) .
These results suggest that ANKRD16 functions as an alternative to water or tRNA Ala , in that it accepts misactivated serine. Previous studies have demonstrated that reactive aminoacyl adenylates may react with cysteine or lysine residues [18] [19] [20] [21] . Levels of precipitated serine were diminished only slightly after prolonged exposure to alkaline pH, which hydrolyses thiol esters (for example, cysteine). As such, the ANKRD16 serine adduct is probably an amide (for example, lysine) (Extended Data Fig. 4i ). 
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We used mass spectrometry to identify the residues of ANKRD16 that accept misactivated serine. No spectral shift was observed with Cys-containing peptides. Although not all Lys-containing peptides of ANKRD16 were resolved, three highly conserved lysines-K102, K135 and K165-shifted by 87 Da, the mass of serine (Extended Data Fig. 1j , Extended Data Fig. 5a-d ). Therefore, we mutated those lysine codons to arginine (ANKRD16(K102R/K135R/K165R, hereafter denoted ANKRD16(3×R)) (Extended Data Fig. 4g ). Circular dichroism spectroscopy and thermal shift assays suggested that wild-type ANKRD16 and ANKRD16(3×R) have similar secondary structures and stabilities (Extended Data Fig. 5e , f), and only a slight change (approximately twofold) in affinity for AlaRS(A734E) (Extended Data Figs. 2f, 5g). In contrast to ANKRD16, ANKRD16(3×R) had no effect on AlaRS(A734E) pre-transfer editing (Fig. 4e , Extended Data Fig. 4b ).
Unlike ANKRD16, which rescued the growth of AlaRS(C666A/ Q584H) E. coli at high concentrations of serine, ANKRD16(3×R) did not rescue the growth of mutant bacteria under these conditions ( Fig. 4f) . Similarly, the expression of ANKRD16, but not ANKRD16(3×R), prevented the serine-induced death of B6.Aars sti/sti embryonic fibroblasts ( Fig. 4g , Extended Data Fig. 6 ). Accordingly, we generated a model for the ANKRD16-AlaRS complex (Fig. 4h ). Modified lysine side chains of ANKRD16 project out from the helixloop-helix motifs, with each in close proximity to the active site of AlaRS, at which serine is misactivated.
Extensive neuron loss in sticky mice lacking Ankrd16
We performed immunofluorescence experiments to determine whether the specificity of neuron death in Aars sti/sti mice is correlated with the levels of ANKRD16. ANKRD16 was widely expressed in the brain and was detected in the nucleus as well as the cytoplasm (Fig. 5a , Extended Data Fig. 7a, b) . Notably, ANKRD16 levels were lower in Purkinje cells relative to cerebellar granule cells, cells of the cerebellar molecular layer, hippocampal neurons, and cells in the cortex (Fig. 5a ).
To test whether the levels of Ankrd16 influence the sensitivity of cells to the Aars sti/sti mutation, we generated an Ankrd16-null allele (Extended Data Fig. 7c, d ). Ankrd16 −/− mutant mice had no obvious pathologies in the brain or other organs, even when aged to 12 months (data not shown). However, loss of Ankrd16 in Aars sti/sti mice resulted in early embryonic lethality (Extended Data Fig. 7e ). These results show that the low levels of ANKRD16 present in B6 mice are sufficient to resolve sti-mediated editing defects induced during embryonic development.
To determine the effect of decreasing ANKRD16 levels on neuronal cell survival, we conditionally deleted Ankrd16 in postnatal Purkinje cells in Aars sti/sti mice. Purkinje cell loss in TgPcp2-Cre Ankrd16 fl/− Aars sti/sti mice began at about three weeks of age; by four weeks of age, the majority of Purkinje cells were absent and, in contrast to Aars sti/sti mice, all Purkinje cells had degenerated by seven months of age (Extended Data Figs. 8a, 9a ). Formation of ubiquitin-and p62-positive aggregates was Biological replicates for c, d: TgCaMKIIa-Cre Ankrd16 fl/− Aars sti/sti : 1.5 months, n = 5; 3 months, n = 7; 7 months, n = 6; Ankrd16 −/− : 7 months, n = 7; Aars sti/sti and wild-type: 7 months, n = 3. Scale bars, 50 μm (a, b, low magnification; c, higher magnification); 10 μm (a, b, higher magnification); 500 μm (c, low magnification); 100 μm (d). CA, cornu ammonis; DAPI, 4ʹ,6-diamidino-2phenylindole; DG, dentate gyrus; P, postnatal day.
Article reSeArcH also accelerated in Purkinje cells, with aggregates observed in 12.3% of Purkinje cells compared to 2.5% of these neurons in Aars sti/sti mice at three weeks of age (Extended Data Fig. 9a ).
Deletion of Ankrd16 in the embryonic cerebellar primordium using En1 cre22 resulted in protein aggregates and neuron death in interneurons in the molecular layer and neurons in the granule cell layer as well as in the Purkinje cells (Extended Data Figs. 8b, c, 9b ). Furthermore, loss of Ankrd16 in postnatal cortical and hippocampal neurons also caused their degeneration. Ubiquitin-and p62-positive aggregates were observed both in hippocampal pyramidal cells (2.80 ± 0.22%) and in cortical neurons in two-month-old TgCaMKIIa-Cre Ankrd16 fl/− Aars sti/sti mice ( Fig. 5b-d, Extended Data Fig. 9c ). Together, these data demonstrate that neurons other than Purkinje cells are also sensitive to the effects of mistranslation, and further suggest that ANKRD16 protects against mistranslation in a dose-dependent fashion.
Discussion
In contrast to known editing mechanisms of tRNA synthetases or free-standing homologues of editing domains that act autonomously 23, 24 , tRNA-independent hydrolysis of misactivated serine by AlaRS is enhanced through the binding of ANKRD16, which captures misactivated serine and removes it from the pool for protein synthesis (Extended Data Fig. 10a, b ). Unlike most tRNA synthetases, AlaRS misactivates amino acids that are both smaller (glycine) and larger (serine) than alanine, owing to structural properties that make it difficult for AlaRS to exclude misactivated serine 2,24-27 . Thus, serine misactivation by AlaRS, and the toxic effects of serine-for-alanine replacements in vertebrates, may present a special situation in which an editing co-factor is necessary for proofreading.
In addition to providing direct mechanistic insights into the editing functions of aminoacyl tRNA synthetases, the discovery of Ankrd16 highlights the importance of studying mRNA translation in higher organisms, and may provide understanding for the cell-type sensitivity of phenotypes associated with the Aars sti mutation. More broadly, cell-type selectivity resulting from 'monogenic' mutations in ubiquitous genes has been difficult to resolve. Only a few modifier genes of disease mutations have been identified in an unbiased approach, and these suggest that modifier genes may function in independent, parallel pathways [28] [29] [30] . Our identification of Ankrd16 as a modifier of the Aars sti mutation demonstrates that this possibility may be an oversimplification, and that restricted pathologies may be due to the expression levels of genes that modify the function of the gene harbouring the primary mutation.
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MEthodS Ethical compliance. All mouse studies were performed under the guidance of the University of California, San Diego and The Jackson Laboratory Animal Care and Use Committee in accordance with institutional and regulatory guidelines. Mice. Genetic mapping of the Msti (modifier of sticky) was performed on N 1 and F 2 mice using polymorphic microsatellite and SNP markers (primer sequences are listed below). In brief, C57BL/6J (B6).Aars sti/+ mice were intercrossed with CAST/E i (CAST) mice and the resulting F 1 Aars sti/+ mice were either backcrossed to B6.Aars sti/+ to generate N 1 Aars sti/sti mice (n = 1,249) or intercrossed to generate F 2 Aars sti/sti mice (n = 766) for phenotypic assessment. Ataxia and Purkinje cell degeneration of N 1 or F 2 Aars sti/sti mice were assessed at three to four months of age. To generate Ankrd16 −/− Aars sti/sti embryos, timed matings between Ankrd16 −/− Aars sti/+ and Ankrd16 −/− Aars sti/+ mice were performed. The day that a vaginal plug was detected was defined as embryonic day 0.5 (E0.5).
To generate heterozygous congenic B6.CAST-Msti mice (Msti CAST/B6 ), B6 and CAST mice were intercrossed and mice carrying the CAST allele at the Msti flanking markers (D2Mit4 and D2Mit427) were backcrossed to B6 mice for seven generations. All transgenic mice were generated by pronuclear injection of B6 zygotes. Tg25L9 transgenic mice were generated by injection of a CAST-derived BAC clone (CH26-25L9). To generate transgenic TgPcp2 Ankrd16 mice, the coding sequence of Ankrd16 CAST cDNA was inserted into the BamHI site of the fourth exon of the L7/Pcp2 minigene 31 . To generate Tg-CAG Ankrd16-Myc transgenic mice, the stop codon of the Ankrd16 CAST cDNA was replaced with three copies of a myc epitope tag and cloned into the EcoRI site of the pCAGGS vector 15 .
Generation of the targeted Ankrd16 allele was performed by homologous recombination of the Ankrd16 locus in R1 embryonic stem cells. Targeted embryonic stem cells were confirmed by Southern blotting. Cells were injected into B6J blastocysts to generate Ankrd16 neo/+ mice, which were backcrossed ten generations to B6J mice. Ubiquitous deletion of exon 2 of Ankrd16 to generate the Ankrd16 +/− allele was accomplished by crossing Ankrd16 neo/+ mice to B6.FVB-Tg(EIIa-cre) C5379Lmgd/J (The Jackson Laboratory, stock #003724). To generate a conditional Ankrd16 fl/+ allele, the neo cassette was removed by crossing Ankrd16 neo/+ mice to B6.129S4-Gt(ROSA)26Sor tm1(FLP1)Dym /RainJ (The Jackson Laboratory, stock #009086). For conditional loss-of-function experiments, the following Cre-lines were used: B6.129-Tg(Pcp2-cre)2Mpin/J (The Jackson Laboratory, stock #004146), En1 tm2(cre)Wrst /J (The Jackson Laboratory, stock #007916), B6.Cg-Tg(Camk2a-cre) T29-1Stl/J (The Jackson Laboratory, stock #005359).
SNP markers are as follows: D2SlacCA3 forward: 5′GCTAGAAAGATGCTGG TAATGGAA3′, D2SlacCA3 reverse: 5′GGCTGGCTGTGTAAGCACAT3′; D2SlacCA6 forward: 5′AACACACCATACCACACACACA3′, D2SlacCA6 reverse: 5′TGGAGGTTTGCAAAGGAATC3′; D2SlacCA8 forward: 5′ATAC CCACCCACATGTGACG3′, D2SlacCA8 reverse: 5′GTACAAGATACTG AGAGTTGGT3′; D2SlacCA10 forward: 5′AGGCTGGAGGACTGTGGGTT3′, D2SlacCA10 reverse: 5′GCGATTGTCCATGGTGGCTT3′; D2SlacCA11 forward: 5′CATCTGGTTTATGTGAATGCC3′, D2SlacCA11 reverse: 5′CAGAGTGCTTTA CCTTTCTC3′; D2SlacCA12 forward: 5′AATGGTCAGCCCTGGAAAC3′, D2SlacCA12 reverse: 5′ACATTCAGCCTGCTTGGTCT3′; D2SlacTAGA1 forward: 5′TGGATGAAGATTTTACAGAT3′, D2SlacTAGA1 reverse: 5′ATCTATC TGTCTGTCTATCC3′; Intr. 5 Ank16 forward: 5′GTAGGGT TGGAGAGATAGCC3′, Intr. 5 Ank16 reverse: 5′TGTGAACACAGTAATAC AGGTGC3′. Rotorod assay. Mice were placed on a rotarod linearly accelerating from 4 to 40 r.p.m. (type 7650, Ugo Basile). The latency to fall was averaged from four trials and repeated over the course of four consecutive test days. A test was considered over when mice fell, 360 s expired, or the mouse used gripping behaviour to remain on the rod. Rotarod experiments were performed with mice of both sexes and at least 15 mice per genotype (Msti B6/B6 Aars +/+ , n = 15; Msti B6/B6 Aars sti/sti , n = 16; Msti CAST/B6 Aars sti/sti , n = 15). Data represent mean ± s.d. and were analysed by twoway ANOVA using Tukey's multiple comparison tests. Histology and immunohistochemistry. Anesthetized mice were transcardially perfused with 4% paraformaldehyde (PFA, for immunofluorescence and histology) or acetic acid/methanol (for calbindin-D28 immunohistochemistry and immunofluorescence; for example, aggregate staining). Tissues were post-fixed overnight and embedded in paraffin. For histological analysis, sections were deparaffinized, rehydrated and stained with cresyl violet according to standard procedures. For immunofluorescence, antigen retrieval on paraformaldehyde-fixed sections was performed by microwaving sections in 0.01 M sodium citrate buffer (pH 6.0, 0.05% Tween-20) three times for 3 min each. Paraformaldehyde-or acetic acid/methanol-fixed sections were incubated with the following primary antibodies: rabbit anti-ubiquitin (DAKO, # Z0458, 1:1,000), mouse anti-ubiquitin (Cell Signaling, #3936, 1:350), guinea pig anti-p62 (ARP, 03-GP62-C, 1:300), rabbit anti-Calbindin D28 (Swant, CB38, 1:300), and guinea pig anti-ANKRD16 (1:200). Guinea pig or rabbit anti-ANKRD16 antibodies were custom-made against recombinant mouse ANKRD16 (1-154 aa) and affinity purified. Detection of primary antibodies was performed with Alexa Fluor-488, -555 or -350 conjugated goat anti-mouse, -rabbit or -guinea pig secondary antibodies (Invitrogen). Sections were counterstained with DAPI, and autofluorescence was quenched with Sudan Black.
For aggregate quantification, the total number of Purkinje cells or hippocampal pyramidal neurons and ubiquitin-or p62-positive neurons were quantified using three sections spaced 100 μm apart per mouse. The percentage of cells with aggregates ± s.d. at different time points were compared between genotypes using multiple t-tests and corrected for multiple comparisons using the Holm-Sidak correction ( Fig. 1c and Extended Data Fig. 9a ). All histological analyses were performed with at least three mice of each genotype and time point, using mice of both sexes. Constructs. For the generation of the various Aars constructs, a full-length mouse Aars clone (Open Biosystems/GE Dharmacon) was used as a template. The wild-type mouse Aars sequence was subcloned and inserted into a mammalian expression vector (pCMV3, Agilent Technologies) via restriction digestion. To generate the mutant AlaRS(A734E) construct, the mutant editing domain of Aars was amplified by PCR from total brain cDNA of B6.Aars sti/sti , TOPO subcloned (TOPO TA cloning kit, ThermoFisher, K450002), and the wild-type editing domain of pCMV3-Aars was replaced with the mutant editing domain (pCMV3-AlaRS(A734E)) via restriction digestion. In addition, wild-type and mutant Aars (pCMV3) were digested and inserted into pCruz HA (C) vector (HA, human influenza haemagglutinin; Santa Cruz, sc-5045). To generate AlaRS deletion constructs (pCMV3-AAD-Aars, pCMV3-ΔAAD-Aars, pCMV3-ΔAAD-AlaRS(A734E)), individual domains of AlaRS were amplified by PCR using either full-length wildtype or mutant Aars constructs, TOPO subcloned, and inserted into pCMV3 vector via restriction digestion. The TgCAG Ankrd16-Myc construct was used to amplify Ankrd16 by PCR, whereas Ankrd29 was amplified from total brain B6J cDNA. PCR products were TOPO subcloned and then inserted into pCMV3 via restriction digestion. QuickChange II Site-Directed Mutagenesis kit (Agilent, #20052) was used to mutate lysines 102, 135 and 165 in ANKRD16 to arginines (ANKRD16(3×R)). Cell culture. Mouse embryonic fibroblasts (MEFs) were prepared by standard procedures 32 . HEK293T (American Type Cell Culture, not authenticated nor tested for mycoplasma contamination) and MEF cells were maintained in Dulbecco's modified Eagle's medium (Sigma) with GlutaMAX (Gibco) and 10% fetal bovine serum at 37 °C in 5% CO 2 . HEK293T cells were transfected with various constructs as listed. Transfections were performed using Lipofectamine 2000 (Invitrogen) according to the manufacturer's protocol and cultured for 48 h before co-IP and western blot analysis.
For the serine toxicity assay, freshly isolated MEFs were cultured in increasing concentrations of serine for 24 h; MEFs were collected and stained with propidium iodide. The percentage of cell death was measured by fluorescence-activated cell sorting (n = 3, Fig. 3d ). Data represent mean ± s.d. and were analysed by two-way ANOVA using Tukey's multiple comparison tests. For fluorescence microscopy (n = 4, Fig. 4g ), Aars sti/sti embryonic fibroblasts were co-transfected with phr-GFP II and either ANKRD16 Flag or ANKRD16(3×R)-Flag using the P4 Primary Cell 4D-Nucleofector X Kit (Lonza), with around 50% transfection and around 95% co-transfection efficiency. 12 h after transfection and seeding, cells were washed twice with PBS and media with either 0.4 mM or 40 mM serine was added for 24 h. Subsequently, cells were stained with propidium iodide (Invitrogen, P21493, 250 ng ml −1 ) and Hoechst 33342 (Life Technologies, H3570, 5 μg ml −1 ) to determine cell death. The number of cells that were propidium iodide-and GFP-positive out of the total GFP-positive cells was determined. About 1,000 cells were counted per genotype and condition. Cell death was expressed as the percentage increase in cell death between low and high serine conditions. Data represent mean ± s.e.m. and were analysed by one-way ANOVA using Tukey's multiple comparison tests. Cell fractionation. Brains from six-week-old mice were isolated and immediately processed for subcellular fractionation as previously described 33, 34 . In brief, brains were excised, immersed in ice-cold PBS, and washed three times. After washing, brain tissue was minced into smaller pieces and homogenized in buffer (0.25 M sucrose, 10 mM HEPES, pH 7.5, protease inhibitor cocktail (Roche)) using a Potter-Elvehjem Tissue Grinder. The homogenate was centrifuged at 1,000g for 10 min to generate a crude cytoplasmic fraction and nuclear fraction for further purification by ultracentrifugation. The supernatant (crude cytoplasmic fraction) from four brains was pooled to purify the mitochondrial, rough endoplasmic reticulum and cytoplasmic fractions, and the pellet (crude nuclear fraction) from two brains was used to purify the nuclear fraction. Eventually, purified pellets (mitochondria, nucleus, rough endoplasmic reticulum) were lysed (4 °C, 30 min) in lysis buffer (50 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% SDS) and proteins from the cytoplasmic fraction were concentrated by ultrafiltration (Millipore, Amicon Ultra-15, #UFC900308). Equal amounts of total protein from each cellular fraction were subject to electrophoresis on SDS-PAGE gels. Reverse transcription, quantitative PCR, and genomic PCR analysis. Cerebella from various inbred strains were isolated and immediately frozen in liquid nitrogen. Total RNA was extracted with TRIzol reagent (Life Technologies). cDNA synthesis was performed on DNase-treated (DNA-free DNA Removal Kit, Life Technologies AM1906) total RNA using oligo(dT) primers and the SuperScript III First-Strand Synthesis System (Invitrogen/Life Technologies). Quantitative RT-PCRs (qRT) were performed using iQ SYBR Green Supermix (Bio-Rad) and an iQ5 Multicolor Real-Time PCR Detection System (Bio-Rad). Reactions were performed with primers either complementary to the CAST or to the B6 Ankrd16 sequence. Both primer sets showed similar results; results using B6 primers are shown in Fig. 2d . Expression of Ankrd16 transcript was normalized to 18S rRNA using the 2 −ΔΔCT method 35 , expressed as fold change ± standard error of the mean (s.e.m.) relative to control (C57BL/6J) and analysed by multiple t-tests using Holm Sidak comparison tests (n = 3). Ankrd16 quantitative and conventional RT-PCR analysis was performed on 50 ng of cerebellar cDNA generated from one-or twomonth-old mice, respectively.
To confirm non-synonymous SNPs of candidate genes, PCRs were performed on genomic DNA from various inbred strains. PCR products were purified (Agencourt AMPure XP-PCR Purification, Beckman Coulter) and subjected to sequencing.
The RT-PCR primers used are as follows: 5′UTR Ankrd16 forward: 5′GTCTT CCTCCTACTTTTGTCCA3′, Exon2 Ankrd16 reverse: 5′CAAG G TTCTTCCTT GTGCAC3′; Exon1 Ankrd16 forward: 5′TCGTGGACTC CTTGAAGAAG3′, Exon3 Ankrd16 reverse: 5′TTCCAAACAGCCGTGCATTG3′, Exon2 Ankrd16 forward: 5′TGATCCTCCGGTACTTGCT3′, Exon5 Ankrd16 reverse: 5′ATCTAC ATCGATGCCAAGACC3′, Exon4 Ankrd16 forward: 5′GCTGCTCCTT GAACAGCATAA3′, Exon6 Ankrd16 reverse: 5′CACCCAAGGACAACAG AGTT3′, Exon5 Ankrd16 forward: 5′CAGCACTTCACTATGCAGCA3′, Exon7 Ankrd16 reverse: 5′CATG GTCAAAGTCCTGAAGGA3′, Exon6 Ankrd16 forward: 5′GTGCCGACATCAACTCTACA3′, 3′UTR Ankrd16 reverse: 5′TGAACGGCCTT GAACTCCAT3′; Exon3 Ankrd16 forward: 5′GCTGTTTGGAAGCAGTCCA3′, Exon5′ Ankrd16 reverse: 5′CCAAGGAAGAGCTTACGCTAT3′.
qRT-PCR primers: Exon 5/6 (B6) forward: 5′TGCAGCAAAGGAAGGAC AGA3′, or Exon 5/6 (CAST) forward: 5′TGCAGCGAAGGAAGGACAGA3′, Exon7 Ankrd16 reverse: 5′GTAGGAGGAGCCTGGTGCAA3′; 18S RNA forward, 5′ GAGGGAGCCTGAGAAACG G 3′, 18S RNA reverse: 5′GTCGGGAG TGGGTAATTTGC3′.
Non-synonymous SNP primers (Msti candidate genes): Il2ra(T101S/Q106H) forward: 5′TCCCATATTCTCCAGCCCAT3′, Il2ra(T101S/Q106H) reverse: 5′CACCTGCCTGTTGAGAACA3′; Il2ra(S143R) forward: 5′TGCTGT GTCT TCCCAAACT T3′, Il12ra(S143R) reverse: 5′CCCGTTTTC CCACACTTCAT3′; Il2ra(G158S) forward: 5′CCACCTCCTTGGAAACATGA3′, Il2ra(G158S) reverse: 5′TCGGTGGTGTTCTCTTTCATC3′; Il2ra(M225T) forward: 5′GCAGTCCTATGCTAGCCATAA3′, Il2ra(M225T) reverse: 5′CGTCTTTGCATGCTTCACC3′; Il2ra(K236Q/M233V) forward: 5′TTAG TGGCCGTTTCAACCAG3′, Il2ra(K236Q/M233V) reverse: 5′CTTGTGCAG TCCTATGCTAGC3′; Fbxo18(H15Q) forward: 5′CCCTATTCCGTCCT TTTGTTC3′, Fbxo18(H15Q) reverse: 5′ATGAGACGGTTTAAGCGGA A3′; Fbox18(P369/376A) forward: 5′ATTAACGTCTGGGCCTTGGT3′, Fbxo18(P369/376A) reverse: 5′TGCTGATGTTAATCCCCTTCTC3′. Ank16 (E335A/T346M) forward: 5′ATCTGGCCTGCGCAGGTCA3′, Ank16(E335A/ T346M) reverse: 5′CTTGAACTCCATCGCCTC3′. Co-immunoprecipitation experiments. Brain or liver tissue from four-week-old Tg-CAG Ankrd16-Myc or non-transgenic mice were isolated and immediately used or frozen in liquid nitrogen. Whole protein lysate from either tissue samples or HEK293T cells was extracted with solubilization buffer (20 mM Tris-HCl (pH 7.4), 137 mM NaCl, 0.1% Triton X-100, Protease Inhibitor Cocktail (Roche)) using a Potter-Elvehjem Tissue Grinder (for tissue samples). Protein extraction was performed at 4 °C for either 45 min (tissue samples) or 30 min (cell culture samples) under gentle agitation. The lysate was centrifuged at 16,000g at 4 °C for either 30 min (tissue samples) or 20 min (cell culture samples). The lysate was precleared in two steps at 4 °C under gentle agitation, first with Dynabeads Protein G (Dynabeads Protein G Immunoprecipitation Kit, Invitrogen, 10007D) for 90 min followed by clearing with normal IgG complex for 90 min (corresponding to the species of IP antibody, Santa Cruz, mouse IgG (sc-2025), or goat IgG (sc-2028)) that was pre-immobilized on Dynabeads Protein G. Subsequently, pre-cleared lysates were incubated with pre-immobilized Dynabeads Protein G with antibody (mouse anti-Myc, Abcam, ab18185; mouse anti-Flag, Sigma, clone M2, F1804; or goat anti-HA, Santa Cruz, HA probe Y-11, sc-805-G) for 3 to 5 h at 4 °C under gentle agitation. After washing with wash buffer (20 mM Tris-HCl (pH 7.4), 137 mM NaCl, 0.5% Triton X-100 (tissue samples) or 20 mM Tris-HCl (pH 7.4), 300 mM NaCl, 0.1% Triton X-100 (cell culture samples)), proteins were eluted by incubation with SDS-PAGE sample buffer for western blotting. Mass spectrometry. Tissue lysates were prepared as described for co-immunoprecipitation and proteins were eluted twice by incubation with 2% SDS for 5 min at 90 °C. After elution, proteins were recovered in 100 mM Tris buffer (pH 7.4), and purified using chloroform/methanol precipitation. Protein pellets were dried using a speed vac and dissolved in 30 μl of 20 mM Tris buffer (137 mM NaCl, pH 7.4). The two elutions for each sample were combined (total volume 60 μl), then mixed with 33.5 μl of 50 mM NH 4 HCO 3 and 1 μl of 0.5 M tris(2-carboxyethyl)phosphine hydrochloride (Thermo Scientific, #20490). Samples were incubated for 20 min, occasionally vortexed, mixed with 2.7 μl of 0.55 M iodoacetamide, incubated for 15 min in the dark, and mixed with 1 μl of 1% ProteaseMax (Promega, V2071) to enhance the subsequent digestion. Trypsin digests were performed at 37 °C overnight following the instructions for 'solution digestion' using Trypsin Singles (2 μg of trypsin per sample, Proteomics Grade, Sigma, T7575), mixed with 5% formic acid (final concentration 0.5%), centrifuged for 30 min at 13,000g, and the supernatant was collected for analysis by mass spectrometry.
For mass spectrometric analysis, a four-step MudPIT analysis was performed using an Accela pump and a Thermo LTQ-XL (ThermoFisher Scientific) using an electrospray stage built in-house 36 . Tandem mass spectra were extracted from raw files using RawExtract 1.9.9 37 and were searched against a Uniprot Mus musculus database with reversed sequences using ProLuCID 38 . The search space included all fully-tryptic and half-tryptic peptide candidates with a fixed modification of 57.02146 C. Proteins were considered putative interaction candidates if they were detected with at least five peptides (total number of peptides). Proteins detected in both transgenic (experimental sample) and non-transgenic (negative sample) tissue were considered non-specific and excluded as putative interaction candidates. Western blotting. Proteins were extracted with RIPA buffer (including Proteinase Inhibitor cocktail, Roche) or solubilization buffer (see above) when used for co-IP experiments, and were resolved on SDS-PAGE gels before transfer to PVDF membranes (GE Healthcare Life Sciences, #10600023) using a tank blotting apparatus (BioRad). After blocking in 5% non-fat dry milk (Cell Signaling, #9999S), blots were probed with primary antibodies at 4 °C overnight: mouse anti-Myc (Abcam, ab18185, 1:1,000), goat anti-Myc (Abcam, ab9132, 1:1,000), rabbit anti-Myc (Abcam, ab9106, 1:2,000), guinea pig anti-ANKRD16 (1:150), rabbit anti-ANKRD16 (1:400), mouse anti-AlaRS (A-6, Santa Cruz, sc-165990, 1:100), rabbit anti-AlaRS (Sigma, HPA040870, 1:500), rabbit anti-GAPDH (Cell Signaling, #2118, 1:6,500), mouse anti-Flag (Sigma, M2 clone, #F1804, 1:5,000), rabbit anti-Flag (Sigma, F-7425, 1:5,000), mouse anti-HA (Covance, MMS-101P, 1:2,000), rabbit anti-Histone 3-HRP (2 h incubation at room temperature, Cell Signaling, #5192, 1:500), rabbit anti-COX IV (Cell Signaling, #4850, 1:5,000), rabbit anti-Grp78 (StressGen, SPA-826, 1:500), goat anti-Sec61β (Santa Cruz, sc-27694, 1:500) and followed by incubation with HRP-conjugated secondary antibodies for 2 h at room temperature: goat anti-rabbit IgG (BioRad, #170-6515), goat anti-mouse IgG (BioRad, #170-6516), bovine anti-goat IgG (Santa Cruz, sc-2384), donkey anti-goat IgG (Santa Cruz, sc-2056), goat anti-guinea pig IgG (Santa Cruz, sc-2903) or donkey anti-guinea pig IgG (Millipore, AP193P). Signals were detected with SuperSignal West Pico Chemiluminescent substrate (Thermo Scientific, #34080). Quantification of protein levels (cerebellum, C57BL/6J, CAST/E i , Aars sti/sti , Aars sti/sti Msti CAST/CAST and Msti CAST/B6 , three-to four-week-old mice, n = 3) and tissue expression (C57BL/6J, Msti CAST/B6 and Msti CAST/CAST , six-week-old mice) of ANKRD16 was determined, normalized to GAPDH, and expressed as a fold change ± s.d. relative to Aars sti/sti and analysed by ordinary one-way ANOVA (Tukey-test). Quantification of binding affinity was determined by normalizing the immunoprecipitation signal to the input signal of AlaRS. Protein expression and purification. Histidine-tagged human or mouse AlaRS (full length and truncations (AlaRS-ΔAAD has an N-terminal SUMO tag)), E. coli AlaRS, human TyrRS, human TrpRS, mouse ANKRD16 and mouse ANKRD29 were expressed in E. coli and purified by Ni-NTA resin (Qiagen), followed by HiLoad 16/60 Superdex 200 prep grade column (GE Healthcare). Glutathione S-transferase (GST)-tagged mouse ANKRD16 was expressed in E. coli and purified by glutathione-Sepharose 4B beads (GE Healthcare), followed by a HiLoad 16/60 Superdex 200 prep grade column. The final purified proteins were stored in the 20 mM HEPES (pH 7.5), 200 mM NaCl, and 1 mM dithiothreitol (DTT). In vitro transcription of tRNA Ala . The DNA template containing a T7 promoter and a tRNA Ala gene was synthesized by PCR of overlapping oligonucleotides. The transcription reaction was performed in 40 mM Tris-HCl (pH 8.0), 25 mM NaCl, 20 mM MgCl 2 , 2 μg ml −1 pyrophosphatase, 0.1 mg ml −1 bovine serum albumin (BSA), 5 mM DTT, 20 mM NTPs with T7 polymerase and the DNA template at 37 °C for 2 h. The tRNA transcript was purified by phenol-chloroform extraction. The purified tRNA was annealed by heating to 95 °C for 3 min and then slowly cooled to room temperature, with addition of 1 mM MgCl 2 at 55 °C. Dipeptide translation experiments. Ribosomal subunits (from E. coli MRE600) and EF-Tu were purified as described 39, 40 . The model mRNA used is identical to m291 41 , except with GCU as codon 2, and was made by in vitro transcription followed by PAGE purification. Native E. coli tRNA fMet was purchased (Chemical Block Ltd) and charged and formylated as described 42 . A transcript corresponding to human tRNA Ala (AGC) was generated in vitro, purified by PAGE and charged with alanine and serine 42 using AlaRS and AlaRS(1-455), respectively.
70S initiation complex was formed by incubating heat-activated 30S subunits (0.2 μM), mRNA (1 μM), formyl-[ 35 S]-Met-tRNA fMet (0.2 μM), 50S subunits (0.6 μM) and 1 mM GTP in buffer A (50 mM K-HEPES pH 7.6, 10 mM KCl, 100 mM NH 4 Cl, 10 mM MgCl 2 , 1 mM DTT) at 37 °C for 30 min. Charged tRNA was used to form the ternary complex by incubating either Ser-tRNA Ala or Ala-tRNA Ala (1 μM) in buffer A with EF-Tu (4 μM), GTP (1 mM), phosphoenol pyruvate (2 mM), and pyruvate kinase (Sigma; 50 μg ml −1 ) at 37 °C for 15 min. The ternary complex was used in reactions at 1 μM. ANKRD16 was purified as above and used in reactions at 4 μM.
For experiments that begin with deacylated tRNA, tRNA Ala (5 μM) was pre-equilibrated at 37 °C with EF-Tu (8 μM), amino acid (for example, 100 μM alanine (Fig. 4a ), 500 μM serine and 1 μM alanine (Fig. 4b) or 500 μM serine (Extended Data Fig. 3c) ), GTP (1 mM), ATP (10 mM), phosphoenol pyruvate (2 mM), pyruvate kinase (50 μg ml −1 ), pyrophosphatase (Roche; 8 ng μl −1 ), and BSA (4 μM) in buffer A, and AlaRS (4 μM) was added to initiate the reaction. Peptide products formed upon reaction of 70S initiation complex and the ternary complex were resolved by electrophoretic thin layer chromatography (eTLC) 43 and quantified using a Typhoon FLA9000 phosphoimager (GE Healthcare). Apparent rates were obtained by fitting the kinetic data to a single exponential equation. E. coli strain construction and halo assay. Editing-defective AlaRS(C666A/ Q584H) E. coli was prepared and the halo assay performed as described 24 . In brief, E. coli were transformed with empty pBAD33/21 vector or pBAD33/21 containing mouse wild-type ANKRD16, ANKRD16(3×R) or mouse ANKRD29. The resulting strains were grown overnight in M9 minimal media with 0.4% glycerol, 0.002% l-arabinose, 0.01 mg ml −1 thiamine and the following antibiotics: kanamycin (50 μg ml −1 ), ampicillin (100 μg ml −1 ), and chloramphenicol (30 μg ml −1 ). Five microlitres of an overnight culture were diluted (1:100) and spread on M9-Kan/ Amp/Cm plates. One hundred microlitres of 1 M l-serine were added to a well cut into the centre of the plate and allowed to diffuse into the agar, creating a radial gradient. Plates were incubated at 37 °C and imaged after 48 h. SwitchSENSE measurements. Wild-type AlaRS, AlaRS(A734E) and AlaRS were coupled to the 5′ end of a 48-mer ssDNA complementary nanolever sequence (cNL-B48) using the Amine Coupling Kit 1 (Dynamic Biosensors), and the products were purified using an ÄKTA start system (GE Life Sciences) equipped with an Anion Exchange Column (Dynamic Biosensors). The cNL-B48 conjugates were then hybridized to a 3′ red-fluorescent labelled 48mer ssDNA nanolever tethered to a biochip electrode. The analyte, wild-type or mutant ANKRD16, was injected onto the electrode in three different concentrations (0.63, 1.25, and 2.50 or 5.00 μM) at a constant flow rate of 50 μl min −1 for 3.5 min and dissociation was observed at a buffer flow rate of 200 μl min −1 for 6 min. Measurements were performed on a DRX2 instrument (Dynamic Biosensors) and switchSENSE technology was employed as previously described 44 . Molecular interactions were recorded at constant negative potential (−0.1 V) on the basis of the changes in the red fluorescence signal upon analyte binding. Kinetic curves were referenced to the corresponding buffer control and kinetic values were determined by global monophasic fitting using switchANALYSIS software (Dynamic Biosensors). Aminoacylation and misacylation assays. Aminoacylation assays were performed as described 7 . In brief, assays were carried out at room temperature using either mouse AlaRS(A734E) alone (50 nM, Extended Data Fig. 3g or 2 Serine-or alanine-linked ANKRD16 (aa-linked ANKRD16) and aminoacylated-tRNA Ala (aa-linked tRNA Ala ) were determined based on aminoacylation reactions with [ 3 H]alanine or [ 3 H]serine using 5 μM AlaRS(A734E) in the presence of 10 μM tRNA Ala and 10 μM ANKRD16. The reaction was incubated for 1 h, then half of the reaction was treated with alkaline pH (Na 2 CO 3 ) for 20 min to hydrolyse acylated tRNA Ala (leaving aa-linked ANKRD16), followed by trichloroacetic acid (TCA) precipitation. Aminoacylated tRNA Ala was the difference between total apparent aminoacylated tRNA (no alkaline hydrolysis) and aa-linked ANKRD16 (after alkaline hydrolysis). Data represent mean ± s.d. and were analysed by a two-tailed Student's t-test. ATP hydrolysis assays. ATPase assays were performed as previously described 45 . Assays measuring the hydrolysis of misactivated serine (Ser-AMP) were carried out at room temperature in a reaction with either 500 nM mouse AlaRS alone, or a mixture of 500 nM AlaRS and 10 μM wild-type ANKRD16, mutant ANKRD16, or ANKRD29 proteins. Reactions also contained 100 mM HEPES (pH 7.5), 40 mM KCl, 10 mM MgCl 2, 0.5 mM ATP, 0.5 μM [α-32 P]ATP, 10 units per ml inorganic pyrophosphatase, 2 mM DTT and 200 mM serine. Two microlitre aliquots of the editing reaction were taken at appropriate time points and quenched in 8 μl 200 mM sodium acetate (pH 5.0), and then 1 μl was spotted on a polyethyleneimine thin-layer chromatography cellulose plate (EMD Millipore) and run in a solution containing 0.1 M ammonium acetate and 5% glacial acetic acid to separate [α-32 P] ATP, [ 32 P]AMP and Ser[ 32 P]AMP. Results were imaged using a phosphoimager. The percentage of hydrolysed AMP (ATPase activity) was quantified with the Molecular Dynamics Image Quant software. Data represent mean ± s.d. and were analysed by one-way ANOVA using Tukey's multiple comparison tests. Far-UV circular dichroism. Circular dichroism spectra were obtained with a CD Spectrometer 400 (Aviv Biomedical, Inc.). Protein samples were prepared at 10 μM in PBS and measurements were scanned from 190 to 260 nm in increments of 0.5 nm at 20 °C. Three independent scans were acquired and averaged for each protein sample. Thermal shift assays. Thermal shift assays were performed using the Protein Thermal Shift Dye Kit (ThermoFisher Scientific) according to the manufacturer's instructions and run on a StepOnePlus 96 Real Time Cycler (Applied Biosystems). In brief, a reaction of 20 μl containing 5.0 μl thermal shift buffer, 12.5 μl of 10 μM wild-type ANKRD16 or ANKRD16(3×R) and 2.5 μl of 8X thermal shift dye were mixed in a 96-well Optical Reaction Plate (Applied Biosystems). The plate was sealed and heated in the StepOnePlus Real-Time PCR from 25 to 90 °C in increments of 0.15 °C. The measurements were performed in four replicates and analysed using the Protein Thermal Shift software (ThermoFisher Scientific). Deacylation assay. The aminoacylation assays were performed at room temperature with 50 mM HEPES (pH 7.5), 20 mM KCl, 5 mM MgCl 2 , 4 mM ATP, 2 mM DTT, 4 μg ml −1 pyrophosphatase, 20 μM cold l-serine, 2.68 μM [ 3 H]serine (1 mCi ml −1 ) as the assay solution. 20 μM tRNA Ala transcript was mixed with the assay solution and the reaction was initiated by adding 5 μM AlaRS protein into the mixture. After 30 min, a phenol-chloroform (pH 5.0) extraction was performed, and the product [ 3 H]serine -tRNA Ala was used as the substrate of the deacylation assay. [ 3 H]serine -tRNA Ala was incubated at room temperature with 100 nM AlaRS (wild-type AlaRS and AlaRS(A734E)) and ANKRD16 protein in assay buffer (50 mM HEPES (pH 7.5), 20 mM KCl, 10 mM MgCl 2 , 5 mM DTT). At varying time intervals, 5 μl aliquots were applied to a MultiScreen 96-well filter plate (0.45 μm pore size hydrophobic, low protein-binding membrane, Merck Millipore Ltd), which was pre-wetted with a quenching solution containing 0.5 mg ml −1 DNA and 100 mM EDTA in 300 mM NaOAc (pH 3.0). After all time points were collected, 100 μl of 20% TCA was added to precipitate the nucleic acids. The plate was then washed four times with 200 μl of 5% TCA containing 100 mM cold serine, then once with 95% ethanol. On drying after completion of the washing steps, 70 μl of 100 mM NaOH was added to elute the tRNA, which was then centrifuged into a 96-well flexible PET microplate (PerkinElmer) with 150 μl of Supermix scintillation cocktail (PerkinElmer). After mixing, the radioactivity in each well of the plate was counted using the 1450 LSC & Luminescence Counter (PerkinElmer). ATP-pyrophosphate exchange assays. The ATP-pyrophosphate exchange assays were performed as previously described 46 . In brief, a reaction mixture of either 250 nM mouse AlaRS(A734E) alone or a mixture of 250 nM AlaRS(A734E) and 10 μM ANKRD16 was incubated at room temperature with 100 mM Tris-HCl (pH 7.5), 10 mM KF, 10 mM MgCl 2, 1 mM ATP, 2 mM DTT, 0.1 mg ml −1 BSA, 20 mM l-serine, and 0.5 mM sodium [ 32 P]pyrophosphate. Filter binding of EF-Tu with aminoacyl-tRNA Ala . The nitrocellulose filter-binding assays were performed as described 47 , with some modifications. Aminoacyl-tRNA Ala was generated in 200 μl aminoacylation reactions containing either 500 nM AlaRS(A734E) alone or a mixture of 500 nM AlaRS(A734E) and 10 μM ANKRD16, in reaction buffer with 50 mM HEPES (pH 7.5), 50 mM KCl, 4 mM ATP, 10 mM MgCl 2, 5 mM DTT, 4 μg ml −1 of inorganic pyrophosphatase (Roche), 50 μM l-alanine or l-serine, 2 μM BSA, and 10 μM in vitro transcript corresponding to human tRNA Ala . Reactions were incubated for 30 min at room temperature. EF-Tu was loaded with GTP in a 200 μl reaction of 2 μM EF-Tu, 3 μM [ 3 H]GTP, 50 mM Tris-HCl (pH 7.4), 50 mM NH 4 Cl, 10 mM MgCl 2 , 3.75 mM phosphoenolpyruvate, 0.05 μg μl −1 pyruvate kinase, which was incubated for 2 min at 37 °C and then placed on ice. An equal volume (200 μl) of the aminoacylation reaction mixture or non-acylated tRNA Ala was added to the [ 3 H]GTP-EF-Tu reaction mixture, incubated for 2 min on ice, and terminated by the addition of 2 ml of a cold wash buffer containing 10 mM Tris-HCl (pH 7.4), 50 mM NH 4 Cl and 10 mM MgCl 2 . The reaction mixture was filtered through a nitrocellulose filter, and the filter was washed with 15 ml of cold wash buffer. The filter was dissolved in a scintillation fluid and counted for radioactivity. The percentage of EF-Tu retained in the membrane was normalized to that retained in the non-acylated tRNA Ala reaction. GST pull-down assay. GST pull-down experiments were performed in buffer containing 20 mM of HEPES (pH 7.5), 200 mM NaCl, 0.5 mM EDTA, 1 mM DTT, 10% glycerol, and 0.1% Triton X-100. Equal amounts of GST-ANKRD16 proteins were incubated with histidine-tagged mouse or human AlaRS (full length and
